Sign Up Today and Learn More About CG Oncology Stock
Invest in or calculate the value of your shares in CG Oncology or other pre-IPO companies through EquityZen's platform.
CG Oncology Stock
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
About CG Oncology Stock
Founded
2010
Headquarters
Irvine, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
CG Oncology Press Mentions
Stay in the know about the latest news on CG Oncology
IPO Roundup: BrightSpring Health Services, CG Oncology, and more
seekingalpha • Jan 22, 2024
The Week's 10 Biggest Funding Rounds: John Chambers' Nile ...
news • Jan 19, 2024
Cretostimogene Grenadenorepvec Produces Durable ...
cancertherapyadvisor • Jan 19, 2024
CG Oncology Sets IPO Target, Looks to Raise Up to $209M
biospace • Jan 19, 2024
Alto, Kyverna Join Growing Number of Biotech IPO Filings in ...
biospace • Jan 19, 2024
CG Oncology Management
Leadership team at CG Oncology
Board Member
Brian Liu
Board Member
Simone Song
Join now and verify your accreditation status to gain access to:
- CG Oncology current valuation
- CG Oncology stock price
- Available deals in CG Oncology and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in CG Oncology stock?
Accredited investors can buy pre-IPO stock in companies like CG Oncology through EquityZen funds. These investments are made available by existing CG Oncology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CG Oncology stock?
Shareholders can sell their CG Oncology stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
